The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries
The FDA is making good on its plans to expand the amount and type of real-world evidence it has on hand to help guide its oversight of marketed drugs and push far past the boundaries of clinical data.
The Oncology Center of Excellence is teaming up with San Francisco-based Syapse to expand beyond electronic health records — or EHRs — in building a multi-sourced program involving data drawn from EHRs and registries, as well as molecular data from testing labs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.